TNF and multidrug-resistant tuberculosis: In addition, MDR-TB patients had higher treatment rates with ICS (6.5% vs. 4.7%, p < 0.01, respectively) and anti-TNF agents (0.3% vs. 0.1%, p < 0.01, respectively) before diagnosis.